Table 1.
Barriers to naloxone access (n = 454µ) and methods of hearing about naloxone program by personal proximity± (n = 416¶).
| Reported barriers | N (%∞) | |||
|---|---|---|---|---|
| COVID orders/physical distancing | 114 (25.1) | |||
| Lack of knowledge about how to access | 60 (13.2) | |||
| Cost | 51 (11.2) | |||
| Transportation | 39 (8.6) | |||
| Time constraints | 30 (6.6) | |||
| COVID-related health concerns | 26 (5.8) | |||
| Stigma | 21 (4.6) | |||
| Supply issue | 14 (3.1) | |||
| None | 99 (21.8) | |||
| Method of learning about program, n (%) | All (n = 416) | Personal proximity (n = 257) |
No personal proximity (n = 159) |
p-value |
|---|---|---|---|---|
| Social media post | 129 (31.0) | 83 (32.3) | 46 (28.9) | 0.471 |
| Word of mouth | 116 (27.9) | 51 (19.8) | 65 (40.9) | <0.001 |
| Online search | 36 (8.7) | 29 (11.3) | 7 (4.4) | 0.015 |
| News (television or print) | 69 (16.6) | 55 (21.4) | 14 (8.8) | 0.001 |
| Health center/harm reduction group | 38 (9.2) | 18 (7.0) | 20 (12.6) | 0.055 |
| Department of public health | 24 (5.6) | 17 (6.6) | 7 (4.4) | 0.347 |
| Advertisement | 4 (1.0) | 4 (1.6) | 0 (0) | 0.114 |
µ
Total number of responses is greater than 422 because respondents could report multiple barriers.
∞
Denominator for percentages is 422.
±
Personal proximity to overdose was defined as witnessing an overdose or personally overdosing in the past year, being worried that someone they know or they will overdose, or having a family member or partner who uses opioids.
¶
Four individuals have missing data on their way of hearing about the naloxone mailing program.